The Life Science sector is one of the most advanced in the world, both in terms of competitiveness
and investment in research.
As the sector evolves, doctors, mathematicians and bioinformaticians
are collaborating more and more closely, with the sole aim of developing solutions that can
improve our lives.
The discovery, development and production of new medical devices and drugs
are governed by strict quality and safety standards as well as intellectual property legal provisions.
Given the difficult context caused by the worldwide pandemic, now more than ever we have
become aware of the importance of this industry